<DOC>
	<DOCNO>NCT01440842</DOCNO>
	<brief_summary>The purpose study ass efficacy , safety feasibility computer-based control algorithm control glucose level adult intensive care unit , comparison standard care .</brief_summary>
	<brief_title>Closed Loop Glucose Control Intensive Care Unit</brief_title>
	<detailed_description>This single centre , open-label , randomise , parallel design , feasibility study conduct Neurosciences Critical Care Unit ( NCCU ) , Addenbrooke 's hospital , Cambridge , UK . Study aim 24 adult subject ( 12 participant arm trial ) study last 49 hour subject . Subjects commercially available Conformité Européenne ( CE ) mark subcutaneous glucose sensor insert start study . Glucose data sensor transmit small bedside tablet computer , contain algorithm determine insulin infusion rate aim maintain glucose level 6.0 - 8.0 mmol/L . The advice algorithm send infusion pump via USB cable insulin deliver intravenously . The system also deliver intravenous glucose via second infusion pump time low glucose level . Samples reference glucose value obtain either arterial line central venous cannula analyse use standard blood gas analyser real time . Subjects randomise standard care receive intravenous insulin base current treatment guideline Neurosciences critical care unit ( NCCU ) , Addenbrooke 's Hospital , Cambridge , UK . The primary outcome time spend target glucose range 6.0 8.0 mmol/L record reference glucose . Secondary outcome time spend glucose level target , record reference glucose , sensor accuracy . Safety include evaluation significant hypoglycaemia hyperglycaemia adverse event .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Aged 18 year older Admitted Neurosciences critical care unit ; ( patient eligible regardless admit diagnosis except specify exclusion criterion ) Stay intensive care unit expect least 48 hour At least one follow condition applies : Not insulin infusion single confirm reference blood glucose level &gt; 10.0 mmol/l Already insulin infusion include subject preexist diabetes . Patients diabetic ketoacidosis hyperosmolar hyperglycaemic nonketotic coma ( HONK ) Patients receive therapeutic hypothermia Known suspect allergy insulin Any disease condition investigator treat physician feel would interfere trial safety patient ( i.e . liver failure , fatal organ failure ) Patients significant abnormality blood clot . Moribund patient likely die within 48 hour Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Stress hyperglycaemia</keyword>
</DOC>